Jeffrey J. Tarrand
About
Jeffrey J. Tarrand is a scholar working on Epidemiology, Infectious Diseases and Oncology.
According to data from OpenAlex, Jeffrey J. Tarrand has authored 135 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Epidemiology, 68 papers in Infectious Diseases and 27 papers in Oncology. Recurrent topics in Jeffrey J. Tarrand's work include Antifungal resistance and susceptibility (49 papers), Fungal Infections and Studies (37 papers) and Bacterial Identification and Susceptibility Testing (20 papers). Jeffrey J. Tarrand is often cited by papers focused on Antifungal resistance and susceptibility (49 papers), Fungal Infections and Studies (37 papers) and Bacterial Identification and Susceptibility Testing (20 papers). Jeffrey J. Tarrand collaborates with scholars based in United States, Greece and Spain. Jeffrey J. Tarrand's co-authors include Dimitrios P. Kontoyiannis, Issam Raad, Johanna Döbereiner, Noel R. Krieg, Xiang Y. Han, Gerald P. Bodey, Russell E. Lewis, Kenneth V. I. Rolston, Ray Hachem and Roy F. Chemaly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Annals of Internal Medicine.
In The Last Decade
Jeffrey J. Tarrand
131 papers receiving 6.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jeffrey J. Tarrand United States | 44 | 3.6k | 3.0k | 974 | 858 | 606 | 135 | 6.6k | ||
| E. Anaissie United States | 52 | 4.5k 1.3× | 5.2k 1.7× | 1.3k 1.3× | 1.3k 1.5× | 283 0.5× | 137 | 9.0k | ||
| Ray Hachem United States | 53 | 4.5k 1.2× | 4.9k 1.6× | 1.1k 1.1× | 1.2k 1.4× | 1.1k 1.8× | 218 | 8.9k | ||
| Markus Ruhnke Germany | 45 | 4.4k 1.2× | 5.0k 1.7× | 535 0.5× | 1.1k 1.2× | 352 0.6× | 151 | 7.0k | ||
| Márcio Nucci Brazil | 54 | 6.8k 1.9× | 8.1k 2.7× | 854 0.9× | 1.7k 2.0× | 617 1.0× | 237 | 11.6k | ||
| Joshua Fierer United States | 55 | 2.9k 0.8× | 2.6k 0.8× | 2.0k 2.1× | 582 0.7× | 275 0.5× | 191 | 11.1k | ||
| Hilmar Wisplinghoff Germany | 40 | 3.6k 1.0× | 4.4k 1.4× | 1.7k 1.8× | 795 0.9× | 1.6k 2.7× | 97 | 8.7k | ||
| William G. Merz United States | 51 | 4.7k 1.3× | 6.0k 2.0× | 776 0.8× | 1.1k 1.3× | 591 1.0× | 146 | 8.1k | ||
| Antonella Mencacci Italy | 45 | 2.8k 0.8× | 3.2k 1.0× | 710 0.7× | 399 0.5× | 320 0.5× | 139 | 6.2k | ||
| Timothy E. Kiehn United States | 39 | 2.7k 0.7× | 2.5k 0.8× | 478 0.5× | 849 1.0× | 605 1.0× | 87 | 4.6k | ||
| Katsunori Yanagihara Japan | 43 | 3.0k 0.8× | 2.6k 0.9× | 1.7k 1.8× | 391 0.5× | 537 0.9× | 470 | 7.3k |
Countries citing papers authored by Jeffrey J. Tarrand
Since
Specialization
Citations
This map shows the geographic impact of Jeffrey J. Tarrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey J. Tarrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey J. Tarrand more than expected).
Fields of papers citing papers by Jeffrey J. Tarrand
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jeffrey J. Tarrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey J. Tarrand. The network helps show where Jeffrey J. Tarrand may publish in the future.
Co-authorship network of co-authors of Jeffrey J. Tarrand
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey J. Tarrand. A scholar is included among the top collaborators of Jeffrey J. Tarrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey J. Tarrand. Jeffrey J. Tarrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Matsuo, Takahiro, Sebastian Wurster, Ying Jiang, Jeffrey J. Tarrand, & Dimitrios P. Kontoyiannis. (2024). Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordance Between Responses of Skin Lesions and Systemic Outcomes. Open Forum Infectious Diseases. 11(2). ofae068–ofae068.
2.
Matsuo, Takahiro, Sebastian Wurster, Ying Jiang, et al.. (2023). Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes. Journal of Antimicrobial Chemotherapy. 79(2). 297–306.
3.
Wurster, Sebastian, Timotheos Paraskevopoulos, Mitsuru Toda, et al.. (2022). Invasive mould infections in patients from floodwater-damaged areas after hurricane Harvey – a closer look at an immunocompromised cancer patient population. Journal of Infection. 84(5). 701–709.
4.
Wurster, Sebastian, Nathaniel D. Albert, Uddalak Bharadwaj, et al.. (2022). Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis. Frontiers in Immunology. 13. 838344–838344.
5.
Magira, Eleni, Ying Jiang, Minas P. Economides, Jeffrey J. Tarrand, & Dimitrios P. Kontoyiannis. (2018). Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre. Mycoses. 61(11). 861–867.
6.
Jung, Dong Sik, Dimitrios Farmakiotis, Ying Jiang, Jeffrey J. Tarrand, & Dimitrios P. Kontoyiannis. (2014). 1446Fungemia due to Uncommon Candida species in Patients with Cancer: Increasing Incidence, Frequent Resistance and High Mortality rates. Open Forum Infectious Diseases. 1(suppl_1). S380–S381.
7.
Farmakiotis, Dimitrios, Jeffrey J. Tarrand, & Dimitrios P. Kontoyiannis. (2014). Efficacy and Tolerability of Micafungin Monotherapy for Candidemia and Deep-Seated Candidiasis in Adults with Cancer. Antimicrobial Agents and Chemotherapy. 58(6). 3526–3529.
8.
Farmakiotis, Dimitrios, Jeffrey J. Tarrand, & Dimitrios P. Kontoyiannis. (2014). Drug-ResistantCandida glabrataInfection in Cancer Patients. Emerging infectious diseases. 20(11). 1833–40.
9.
Lewis, Russell E., Konstantinos Leventakos, Georgios Chamilos, et al.. (2013). Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study. Mycoses. 56(6). 638–645.
10.
McGrath, Danielle M., E. Magda Barbu, Wouter H. P. Driessen, et al.. (2013). Mechanism of action and initial evaluation of a membrane active all- D -enantiomer antimicrobial peptidomimetic. Proceedings of the National Academy of Sciences. 110(9). 3477–3482.
11.
Shah, Dimpy P., Jharna N. Shah, Karen J. Vigil, et al.. (2012). Characteristics and Outcomes of Pandemic 2009/H1N1 Versus Seasonal Influenza in Children With Cancer. The Pediatric Infectious Disease Journal. 31(4). 373–378.
12.
Rolston, Kenneth V. I., Coralia N. Mihu, & Jeffrey J. Tarrand. (2011). Current microbiology of percutaneous endoscopic gastrostomy tube (PEG tube) insertion site infections in patients with cancer. Supportive Care in Cancer. 19(8). 1267–1271.
13.
Tarrand, Jeffrey J., et al.. (2010). Epstein‐Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia. Cancer. 116(4). 880–887.
14.
Ben‐Ami, Ronen, Russell E. Lewis, Jeffrey J. Tarrand, Konstantinos Leventakos, & Dimitrios P. Kontoyiannis. (2009). Antifungal Activity of Colistin against Mucorales Species In Vitro and in a Murine Model of Rhizopus oryzae Pulmonary Infection. Antimicrobial Agents and Chemotherapy. 54(1). 484–490.
15.
Safdar, A., Gabriel Rodriguez, Maya Balakrishnan, Jeffrey J. Tarrand, & K. V. I. Rolston. (2006). Changing trends in etiology of bacteremia in patients with cancer. European Journal of Clinical Microbiology & Infectious Diseases. 25(8). 522–526.
16.
Pham, Audrey S., et al.. (2003). Catheter‐Related Bacteremia Caused by the Nocardioform ActinomyceteGordonia terrae. Clinical Infectious Diseases. 36(4). 524–527.
17.
Hanna, Hend, Issam Raad, Jan Umphrey, et al.. (2000). Control of Nosocomial Clostridium difficile Transmission in Bone Marrow Transplant Patients. Infection Control and Hospital Epidemiology. 21(3). 226–228.
18.
Raad, Issam, Steve Davis, Asma Khan, et al.. (1992). Impact of Central Venous Catheter Removal on the Recurrence of Catheter-Related Coagulase-Negative Stahylococcal Bacteremia. Infection Control and Hospital Epidemiology. 13(4). 215–221.
19.
Scott, M G, Jeffrey J. Tarrand, Dan L. Crimmins, et al.. (1989). Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. II. IgG antibodies contain VH genes from a single VH family and VL genes from at least four VL families.. The Journal of Immunology. 143(1). 293–298.
20.
Vannier, Ann M., Jeffrey J. Tarrand, & Patrick R. Murray. (1988). Mycobacterial cross contamination during radiometric culturing. Journal of Clinical Microbiology. 26(9). 1867–1868.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by E. Anaissie Breakdown of academic impact, for papers by Ray Hachem Breakdown of academic impact, for papers by Markus Ruhnke Breakdown of academic impact, for papers by Márcio Nucci Breakdown of academic impact, for papers by Joshua Fierer Breakdown of academic impact, for papers by Hilmar Wisplinghoff Breakdown of academic impact, for papers by William G. Merz Breakdown of academic impact, for papers by Antonella Mencacci Breakdown of academic impact, for papers by Timothy E. Kiehn Breakdown of academic impact, for papers by Katsunori Yanagihara